No Data
No Data
No Data
No Data
No Data
TenX Keane Acquisition Announces Contribution to Trust Account in Connection With Extension Amendment Proposal
New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (NASDAQ:TENKU, TENK, TENKR)) (the "Company"), announced today that if the proposal to amend the Company's Amended and Restated Memorandum and
GlobeNewswireJan 10 14:29 ET
Citius Pharmaceuticals Executes Definitive Agreement To Merge Wholly Owned Subsidiary With TenX Keane Acquisition To Form Publicly Listed Citius Oncology, Inc.
Upon closing, pursuant to the terms of the merger agreement, Citius Pharma would receive 67.5 million shares in Citius Oncology at $10 per share and retain majority ownership of approximately 90%. The
BenzingaOct 24, 2023 07:35 ET
Express News | TenX Keane Acquisition Extends Deadline for Initial Business Combination
Moomoo 24/7Jul 19, 2023 03:29 ET
TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination
New York, NY, July 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the "Company") (NASDAQ:TENKU) today announced that, in order to extend the date by which the Company must complete its initial business
GlobeNewswireJul 18, 2023 16:00 ET
TenX Keane Acquisition Corp.'s (NASDAQ:TENKU) Lock-Up Period Will Expire on April 12th
TenX Keane Acquisition's (NASDAQ:TENKU – Get Rating) lock-up period is set to end on Wednesday, April 12th. TenX Keane Acquisition had issued 6,000,000 shares in its public offering on October 14th. T
Financial News LiveApr 12, 2023 01:31 ET
Express News | News On TenX Keane Acquisition (TENKU) Now Under TENK
Moomoo 24/7Dec 7, 2022 17:09 ET
No Data
No Data